Non-Interventional Observational Study With Viramune Plus Antiretroviral in HIV Infected Patients

CompletedOBSERVATIONAL
Enrollment

605

Participants

Timeline

Start Date

March 31, 2009

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
HIV Infections
Trial Locations (66)

Unknown

Boehringer Ingelheim Investigational Site 14, Aachen

Boehringer Ingelheim Investigational Site 12, Berlin

Boehringer Ingelheim Investigational Site 13, Berlin

Boehringer Ingelheim Investigational Site 15, Berlin

Boehringer Ingelheim Investigational Site 19, Berlin

Boehringer Ingelheim Investigational Site 21, Berlin

Boehringer Ingelheim Investigational Site 23, Berlin

Boehringer Ingelheim Investigational Site 24, Berlin

Boehringer Ingelheim Investigational Site 28, Berlin

Boehringer Ingelheim Investigational Site 30, Berlin

Boehringer Ingelheim Investigational Site 31, Berlin

Boehringer Ingelheim Investigational Site 34, Berlin

Boehringer Ingelheim Investigational Site 38, Berlin

Boehringer Ingelheim Investigational Site 41, Berlin

Boehringer Ingelheim Investigational Site 54, Berlin

Boehringer Ingelheim Investigational Site 60, Berlin

Boehringer Ingelheim Investigational Site 63, Berlin

Boehringer Ingelheim Investigational Site 8, Berlin

Boehringer Ingelheim Investigational Site 58, Bochum

Boehringer Ingelheim Investigational Site 50, Chemnitz

Boehringer Ingelheim Investigational Site 53, Cologne

Boehringer Ingelheim Investigational Site 61, Cologne

Boehringer Ingelheim Investigational Site 48, Dortmund

Boehringer Ingelheim Investigational Site 27, Duisburg

Boehringer Ingelheim Investigational Site 49, Düsseldorf

Boehringer Ingelheim Investigational Site 62, Düsseldorf

Boehringer Ingelheim Investigational Site 9, Düsseldorf

Boehringer Ingelheim Investigational Site 32, Frankfurt

Boehringer Ingelheim Investigational Site 59, Frankfurt

Boehringer Ingelheim Investigational Site 65, Frankfurt

Boehringer Ingelheim Investigational Site 57, Freiburg im Breisgau

Boehringer Ingelheim Investigational Site 56, Fürth

Boehringer Ingelheim Investigational Site 29, Giessen

Boehringer Ingelheim Investigational Site 33, Hamburg

Boehringer Ingelheim Investigational Site 42, Hamburg

Boehringer Ingelheim Investigational Site 47, Hamburg

Boehringer Ingelheim Investigational Site 51, Hamburg

Boehringer Ingelheim Investigational Site 40, Hanover

Boehringer Ingelheim Investigational Site 43, Hanover

Boehringer Ingelheim Investigational Site 46, Hanover

Boehringer Ingelheim Investigational Site 6, Karlsruhe

Boehringer Ingelheim Investigational Site 25, Koblenz

Boehringer Ingelheim Investigational Site 37, Krefeld

Boehringer Ingelheim Investigational Site 11, Leipzig

Boehringer Ingelheim Investigational Site 52, Mainz

Boehringer Ingelheim Investigational Site 18, München

Boehringer Ingelheim Investigational Site 20, München

Boehringer Ingelheim Investigational Site 22, München

Boehringer Ingelheim Investigational Site 26, München

Boehringer Ingelheim Investigational Site 35, München

Boehringer Ingelheim Investigational Site 5, München

Boehringer Ingelheim Investigational Site 16, Münster

Boehringer Ingelheim Investigational Site 17, Münster

Boehringer Ingelheim Investigational Site 39, Münster

Boehringer Ingelheim Investigational Site 55, Münster

Boehringer Ingelheim Investigational Site 10, Neuss

Boehringer Ingelheim Investigational Site 36, Oldenburg

Boehringer Ingelheim Investigational Site 64, Osnabrück

Boehringer Ingelheim Investigational Site 7, Pforzheim

Boehringer Ingelheim Investigational Site 66, Potsdam

Boehringer Ingelheim Investigational Site 1, Stuttgart

Boehringer Ingelheim Investigational Site 3, Stuttgart

Boehringer Ingelheim Investigational Site 4, Stuttgart

Boehringer Ingelheim Investigational Site 45, Troisdorf

Boehringer Ingelheim Investigational Site 2, Wiesbaden

Boehringer Ingelheim Investigational Site 44, Wuppertal

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY